4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-016086
Director acquired 8,876 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Powell Andrew Kenneth William Director | 2020-03-02 | Option exercise | +8,876 | 9,376 | D | ||
| Derivatives | |||||||
| Powell Andrew Kenneth William Director | 2020-03-02 | Grant or award · Restricted stock units | +8,876 | 8,876 | D | ||
| Powell Andrew Kenneth William Director | 2020-03-02 | Option exercise · Restricted stock units | −8,876 | 0 | D | ||
Loading xslF345X03/doc4.xml…